Robert Weigle

Robert K. Weigle is the CEO of NOWDiagnostics (NOWDx), a role they have held since April 1, 2023. They previously served as CEO of AEENA DX from October 2020 to March 2023. They were the CEO of Benvenue Medical from May 2009 to August 2020, where they led growth from pre-clinical to successful clinical trials and the commercial launch of first-generation devices in two markets. They currently serve as a board member at Tenon Medical, Inc. and as Chief Executive Officer of Prime Genomics, and they were a board member at Zyga from 2013 to 2017. They hold a BA from the University of California, Berkeley.